4D Molecular Therapeutics, Inc. Annual Operating Margin in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
4D Molecular Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to 2023.
  • 4D Molecular Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -5.58K %, a 1070% decline year-over-year.
  • 4D Molecular Therapeutics, Inc. annual Operating Margin for 2023 was -545 %, a 84.5% increase from 2022.
  • 4D Molecular Therapeutics, Inc. annual Operating Margin for 2022 was -3.52K %, a 789% decline from 2021.
  • 4D Molecular Therapeutics, Inc. annual Operating Margin for 2021 was -395 %, a 5% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -545 +2.97K +84.5% Jan 1, 2023 Dec 31, 2023
2022 -3.52K -3.12K -789% Jan 1, 2022 Dec 31, 2022
2021 -395 +20.8 +5% Jan 1, 2021 Dec 31, 2021
2020 -416 +310 +42.7% Jan 1, 2020 Dec 31, 2020
2019 -727 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.